Farringdon Capital, Ltd. West Pharmaceutical Services Inc Transaction History
Farringdon Capital, Ltd.
- $393 Billion
- Q3 2025
A detailed history of Farringdon Capital, Ltd. transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Farringdon Capital, Ltd. holds 799 shares of WST stock, worth $208,826. This represents 0.05% of its overall portfolio holdings.
Number of Shares
799
Previous 1,064
24.91%
Holding current value
$208,826
Previous $233 Million
9.97%
% of portfolio
0.05%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding WST
# of Institutions
853Shares Held
68MCall Options Held
285KPut Options Held
106K-
Vanguard Group Inc Valley Forge, PA9.7MShares$2.54 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY7.58MShares$1.98 Billion0.06% of portfolio
-
State Street Corp Boston, MA3.21MShares$838 Million0.03% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.77MShares$724 Million1.11% of portfolio
-
Brown Advisory Inc2.5MShares$653 Million0.92% of portfolio
About WEST PHARMACEUTICAL SERVICES INC
- Ticker WST
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,033,000
- Market Cap $19.3B
- Description
- West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...